Bumrungrad Hospital Public Company Limited
BH
株式のランク
#3601
Bumrungrad Hospital Public Company Limited functions as a leading healthcare... Bumrungrad Hospital Public Company Limited functions as a leading healthcare provider, overseeing a network of medical facilities operating both domestically in Thailand and internationally. Its medical centers offer a full range of services, including sophisticated diagnostic procedures, diverse therapeutic treatments, and critical intensive care. The company boasts a broad spectrum of specialized outpatient clinics, numbering around 56, which cater to an extensive array of medical needs from allergy and cardiology to cancer care, women's health, and rehabilitation. This includes specialized centers for behavioral health, dental services, diabetes management, emergency care, fertility, health screening, neurosciences, orthopedics, plastic surgery, and sports medicine, among numerous other specialties. Beyond direct patient care, Bumrungrad is also involved in managing real estate assets, conducting clinical research, distributing pharmaceuticals and medical supplies, operating a dedicated training and development center for healthcare professionals, and providing patient referral services. Founded in 1980 and based in Bangkok, Thailand, the company maintains a significant operational footprint, featuring 580 hospital beds.
株価
$5.85
時価総額
$4.65B
変化（1日）
0.00%
変化（1年）
6.02%
国
TH
取引 Bumrungrad Hospital Public Company Limited (BH)
カテゴリー
Healthcare
Bumrungrad Hospital Public Company Limited（BH）の配当履歴
Bumrungrad Hospital Public Company Limited（証券コード：BH）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのBumrungrad Hospital Public Company Limited（BH）の配当履歴
年間配当支払い
| 年 | 配当（株式分割調整済み） | 変化 |
|---|---|---|
| 提供された日付のデータは十分ではありません。 | ||
すべての配当支払いの一覧
| 年 | 配当 | 変化 |
|---|---|---|
| 提供された日付のデータは十分ではありません。 | ||
同業他社や競合企業の配当履歴
| 企業 | 配当支払い回数 | 国 |
|---|---|---|
| 37.00% |
US
|
|
| 0.00% |
DE
|
|
| 49.00% |
US
|
|
| 45.00% |
SA
|
|
| 22.00% |
BR
|
